MSK Ultrasound Moves Beyond Diagnosis

Musculoskeletal ultrasound is widening its role from diagnostic imaging to real-time guidance for minimally invasive procedures. It now supports biopsies, aspirations, injections, percutaneous releases and therapeutic drainages while avoiding ionising radiation. A 2026 overview in the British Journal of Radiology examines how high-frequency probes, microvascular imaging, needle-tracking systems and robotic probe steering are extending its use across complex anatomical regions, including the spine and peripheral nerves. The modality’s portability and point-of-care availability also make it relevant across radiology, orthopaedics, sports medicine, pain management and rehabilitation.

Technology and Clinical Reach

MSK-US combines diagnostic imaging with procedural guidance in a single workflow. It enables dynamic visualisation of tissues and can support early detection, characterisation and monitoring of traumatic injuries, arthritis, synovitis, fractures, tendon healing and synovial inflammation. Its established interventional uses include barbotage for calcific tendinopathy, hydrodilatation for adhesive capsulitis, tumour biopsies, drainages of Baker’s cysts, haematomas and abscesses, intra-articular and bursal injections, nerve blocks and intratendinous or intramuscular injections.

Equipment selection remains central to safe and effective practice. A minimum-standard setup includes a broadband linear transducer for superficial joints and soft tissues, with a low-frequency curvilinear probe for deep targets, intra-pelvic regions or patients with high body mass index. Contemporary systems require real-time imaging, B-mode and Doppler functions and compound imaging to improve tissue contrast and needle visibility. High-end platforms add harmonic imaging, beam steering, tissue elastography and needle-tracking systems. Small-footprint transducers support access to restricted spaces such as small joints, tendons and peri-neural regions.

Portable systems increasingly support bedside and intraoperative applications, while premium consoles remain important for complex interventions. Across settings, aseptic technique, sterile probe sheaths, efficient disinfection and ergonomic workflow remain essential to procedural safety and efficiency.

Broader Procedures and Surgical Alternatives

Ultrasound-guided interventions are moving beyond extremity procedures into more complex regions, including the spine and peripheral nerves. Within spinal care, ultrasound guidance supports needle insertion, facet joint injections and epidural access techniques, providing real-time imaging without ionising radiation. US-MRI fusion imaging also supports spinal interventions by aligning recent MRI scans with real-time ultrasound, enabling spatial orientation for nerve root and facet joint targeting. Reported accuracy for fixed structures reaches the millimetre range, while pain relief appears comparable to conventional fluoroscopy in early evidence.

Must Read: Updated PoCLUS Guidance Refines Bedside Lung Assessment

Intraoperative ultrasound guidance also supports minimally invasive musculoskeletal surgery. High-frequency linear probes and high-definition displays allow real-time visualisation of muscles, tendons, ligaments and nearby blood vessels. This helps guide tendon repairs, treatment of muscle cysts or masses and access to deep joints while reducing risk to vital structures.

Several hand and upper limb conditions illustrate the clinical shift. Ultrasound-guided release for De Quervain’s disease enables controlled division of the first dorsal extensor compartment. Ultrasound-guided trigger finger release supports visualisation of tendon movement and pulley anatomy, with faster recovery than open surgery in comparative findings. Ultrasound-guided procedures also support Dupuytren’s contracture, carpal tunnel syndrome, median nerve compression at the elbow, epicondylitis, long head of biceps tendon tenotomy, chronic exertional compartment syndrome and radial or ulnar nerve release. In selected cases, these approaches reduce soft-tissue disruption, scarring and recovery time.

Therapeutic Agents and Evidence Limits

Ultrasound guidance is also shaping the use of therapeutic agents in musculoskeletal care. Hyaluronic acid injections are increasingly used for intra-articular and peritendinous applications. In knee and hip osteoarthritis, ultrasound-guided administration can reduce pain, improve function and provide a favourable safety profile. In tendinopathies, guided peritendinous injections are associated with pain relief, reduced tendon thickness and decreased neovascularisation, although further controlled evaluation remains necessary for several joints and enthesopathies.

Platelet-rich plasma has gained clinical use for musculoskeletal soft-tissue injuries, but responses vary by tendon and benefits usually develop over months. Its biological rationale includes release of factors involved in angiogenesis, collagen synthesis and tissue remodelling. However, systematic evaluations show limited evidence of superiority over standard treatments for most musculoskeletal conditions. Some benefit appears in chronic plantar fasciitis and non-surgical rotator cuff disease, while routine use remains unsupported for several other indications.

Prolotherapy offers a regenerative injection option using hyperosmolar solutions under ultrasound guidance, but current evidence remains limited and it remains a second-line option after conservative measures fail. Mesenchymal stem cell therapy shows promise for tendon disorders, with potential effects on pain, function and tissue regeneration, but methodological limitations and long-term safety concerns persist. Corticosteroids and local anaesthetics also require caution, as cartilage toxicity, chondrocyte effects and uncommon tendon or ligament rupture remain part of the safety discussion.

MSK-US now supports a broad range of diagnostic, interventional and minimally invasive surgical applications across musculoskeletal care. Its practical value comes from real-time guidance, portability, lack of ionising radiation and capacity to improve procedural precision. Advanced probes, Doppler techniques, microvascular imaging, needle tracking, fusion imaging and robotic systems are expanding access to complex targets. At the same time, biological therapies, corticosteroids and local anaesthetics require careful selection because evidence and safety profiles vary. Standardised protocols, specialist training and stronger clinical validation remain central to further adoption.

Source: British Journal of Radiology

Image Credit: iStock